https://www.barrons.com/articles/pfizer-stock-earnings-paxlovid-vaccine-sales-51651583115
I think these are quite solid results. I just hope the company takes advantage of the growth opportunities ahead. Thoughts?
There are no replies in this thread yet. Be the first to post a reply below: